Search results

Jump to navigation Jump to search
  • ...for preventing ''T. vaginalis'' is bovine vaccines for cattle (cows). The vaccine contains Trichomonas cells or antigens and can be used in combination with 5) “Bovine vaccine compositions and method for preventing trichomonas infections using same”
    16 KB (2,181 words) - 02:17, 17 October 2013
  • ...uires the highest containment facilities; it responds to no treatment or [[vaccine]], causes a high fatality rate in humans, and can be spread from person to ...onkeys with an inhibitor of [[coagulation]] or with [[antisense]] drugs. [[Vaccine]] development has also had success only in monkeys, in whom vaccines for bo
    16 KB (2,467 words) - 09:03, 9 August 2023
  • Vaccine treatments were made from the usage of recombinant adenovirus vectors. This
    8 KB (1,284 words) - 04:46, 16 November 2013
  • The vaccine against Type A H5N1 exists and is kept in U.S. Strategic National Stockpile
    8 KB (1,273 words) - 11:16, 15 September 2013
  • ...lasmids with drug resistant bands. This [[strain]] was used to develop the vaccine for infections caused by ''S. typhi.'' ...information, officials in Pakistan and Indonesia have introduced the[[ Vi vaccine]] to be administered in schools to young children. However, the article poi
    20 KB (3,123 words) - 09:37, 6 March 2024
  • ...he [[Society for Inoculating the Poor]] which provided free [[smallpox]] [[vaccine|vaccinations]]. He also had a profitable apprenticeship program, teaching
    9 KB (1,355 words) - 07:31, 20 April 2024
  • ...ttp://www.aapsonline.org/press/nrvacres.htm Doctors' group votes to oppose vaccine mandates], a 2000 press release from AAPS. Other sources: [http://conwebwat
    11 KB (1,540 words) - 07:09, 26 March 2024
  • .... Genes involved in the infection process will be prime targets for future vaccine development, according to Pearson, although she says that years of addition
    10 KB (1,444 words) - 03:49, 2 December 2010
  • ...his lack of cross immunity is what poses a problem in the development of a vaccine for Dengue. The Dengue virus causes a less lethal condition known as Dengue
    12 KB (1,875 words) - 12:55, 18 May 2009
  • ...evading the human immune response. It has not yet been possible to find a vaccine to prevent the disease.
    11 KB (1,712 words) - 22:05, 7 February 2010
  • ...e of Health is researching whether LGG improves immune response to the flu vaccine. Another study that currently in progress is examining if giving LGG to pre
    11 KB (1,707 words) - 00:27, 15 November 2013
  • A commercial human Q fever vaccine (Q-Vax) is manufactured in Australia but is not available in the United Sta
    11 KB (1,621 words) - 05:11, 31 May 2009
  • ...ans on dental caries is being studied with the hopes of creating a carries vaccine. It is proposed that salivary immunoglobulin A antibody may be viewed as an
    11 KB (1,619 words) - 17:36, 16 February 2010
  • ...became assistant bacteriologist to Sir [[Almroth Wright]], a pioneer in [[vaccine]] therapy and immunology. He gained M.B. and then B.Sc. with Gold Medal in
    11 KB (1,713 words) - 07:31, 20 April 2024
  • ...s been about 30 cases reported worldwide. Unfortunately, there is still no vaccine to prevent brucellosis. All breeding dogs are tested year round to prevent
    12 KB (1,919 words) - 00:28, 14 November 2013
  • ...or standardization, both concerning safety, efficacy, and stability of the vaccine and in its medical uses. Whereas standardization was fairly successful in t
    31 KB (4,567 words) - 15:35, 30 October 2013
  • Any person or facility administering [[vaccine]]s<ref name=AuNT-Vac>{{citation
    12 KB (1,718 words) - 14:14, 21 June 2014
  • ...worked in India, was the first [[microbiologist]] who developed and used [[vaccine]]s against [[cholera]] and [[bubonic plague]]. ...al government of the [[United States of America]] established a [[Smallpox vaccine|smallpox vaccination]] program for Native Americans.<ref>[http://muse.jhu.e
    33 KB (4,747 words) - 08:56, 2 March 2024
  • It was the first bacterium to be used for the preparation of a [[vaccine]] based on attenuated bacteria by [[Louis Pasteur]] in 1881.
    13 KB (2,023 words) - 10:26, 27 March 2024
  • There is currently no vaccine available for either virus. Because HSV 2 is spread more commonly by sexual
    15 KB (2,300 words) - 14:09, 1 November 2010
View ( | ) (20 | 50 | 100 | 250 | 500)